Overview: California Workers' Compensation and CRPS
Complex Regional Pain Syndrome (CRPS), formerly reflex sympathetic dystrophy (RSD), is a recognized painful condition in California workers' compensation when it arises out of and in the course of employment. Under Workers' Compensation Code 5912 and applicable Medical Utilization Schedule (MUS) rules, treatment must be reasonable, necessary, and supported by documented medical evidence. Key variables include objective findings, timely reporting, and impairment-related care. This overview focuses on how the California system defines, covers, and manages CRPS after work injury; it does not replace legal advice or a full medical record review.
- Overview: California Workers' Compensation and CRPS
- Coverage Basics and Claim Factors
- Establishing the Connection
- Key Claim and Treatment Variables
- Treatment Options and Medical Necessity
- Nonsurgical and Noninvasive Options
- Interventional and Surgical Considerations
- Provider Obligations and Documentation
- Claim Outcomes and Next Steps
More from this site
Keep reading the latest coverage
Coverage Basics and Claim Factors
Establishing the Connection
For CRPS to be compensable in California, a medical provider must link the syndrome to a qualifying workers' compensation event. Factors affecting coverage include clear documentation of pain disproportionate to the initial injury, autonomic signs, trophic changes, and early involvement of pain management and physical therapy. Late or unclear onset requires careful medical-legal assessment to distinguish preexisting, idiopathic, or iatrogenic causes.
Key Claim and Treatment Variables
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Primary Diagnosis Coding | ICD-10 G90.5 (CRPS I), G90.0 (CRPS II) | MUS/Statute |
| Initial Treatment Timeline | Prompt (within days to weeks of injury) | Utilization Review |
| Common First-Line Therapies | Physical therapy, occupational therapy, medication management | MUS/Clinical Guidelines |
| Considered Interventions | Sympathetic blocks, spinal cord stimulation, ketamine infusions (case-dependent) | Approved MUS/Medical Policy |
| Maximum Medical Improvement (MMI) | Variable; documented plateau of function and pain | IME/Peer Review |
Treatment Options and Medical Necessity
California MUS requires each CRPS intervention to be medically necessary and consistent with evidence-based care. Early, aggressive physical and occupational therapy is emphasized to preserve function and reduce disuse-related deterioration. Outpatient programs, aquatic therapy, and graded activity plans are common. Pharmacologic strategies may include gabapentinoids, antidepressants, topical agents, and, in refractory cases, carefully monitored opioid therapy with a documented risk mitigation plan.
Nonsurgical and Noninvasive Options
- Physical therapy with desensitization, mirror therapy, and graded motor imagery
- Occupational therapy for adaptive techniques and splinting as needed
- Psychological support (CBT) for pain coping, sleep, and mood comorbidity
- Regional sympathetic blocks for diagnostic and short-term therapeutic purposes
- Pharmacologic management aligned with MUS formularies and utilization review
Interventional and Surgical Considerations
When conservative measures fail, procedures such as continuous peripheral nerve blocks, spinal cord stimulation, or intrathecal baclofen may be considered. These require prior authorization, documentation of failed conservative care, and confirmation that the proposed intervention is likely to improve function or pain. Experimental or off-label therapies generally need additional review and approval.
Provider Obligations and Documentation
Treating clinicians must maintain detailed, objective records: baseline and serial assessments, validated pain and function measures, treatment plans with measurable goals, and justifications for any escalation or deviation from standard pathways. Accurate coding (G90.x), clear medical necessity notes, and coordination with authorized providers help prevent delays or denials. Workers' compensation pharmacy and utilization review processes should be engaged early when considering advanced or high-cost therapies.
Claim Outcomes and Next Steps
Approved CRPS treatment plans in California typically include defined durations for trial therapies, scheduled reevaluations, and predefined criteria for further escalation or transition to maintenance. Denials commonly hinge on insufficient evidence of work-relatedness, lack of documented medical necessity, or noncompliance with treatment protocols. Employers and carriers should ensure timely responses and transparent communication; providers should submit complete records and, when needed, request independent medical evaluation or peer review to support continued care.